| Literature DB >> 25434817 |
Yongqing Liu1, Xiaoqin Lu2, Li Huang3, Wei Wang2, Guomin Jiang2, Kevin C Dean2, Brian Clem4, Sucheta Telang4, Alfred B Jenson4, Miriam Cuatrecasas5, Jason Chesney4, Douglas S Darling6, Antonio Postigo7, Douglas C Dean1.
Abstract
Ras pathway mutation is frequent in carcinomas where it induces expression of the transcriptional repressor ZEB1. Although ZEB1 is classically linked to epithelial-mesenchymal transition and tumour metastasis, it has an emerging second role in generation of cancer-initiating cells. Here we show that Ras induction of ZEB1 is required for tumour initiation in a lung cancer model, and we link this function to repression Pten, whose loss is critical for emergence of cancer-initiating cells. These two roles for ZEB1 in tumour progression can be distinguished by their requirement for different levels of ZEB1. A lower threshold of ZEB1 is sufficient for cancer initiation, whereas further induction is necessary for tumour metastasis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25434817 DOI: 10.1038/ncomms6660
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919